摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Amino-5-(p-tolyl)pyrazine | 59489-73-5

中文名称
——
中文别名
——
英文名称
2-Amino-5-(p-tolyl)pyrazine
英文别名
5-(4-Methylphenyl)pyrazin-2-amine
2-Amino-5-(p-tolyl)pyrazine化学式
CAS
59489-73-5
化学式
C11H11N3
mdl
——
分子量
185.228
InChiKey
RZSGKUUISFOIBT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel 1-(mono-o-substituted benzoyl)-3-(substituted pyrazinyl) ureas
    摘要:
    新颖的1-(取代苯甲酰基)-3-(取代吡啶基)脲类化合物,具有杀虫剂活性,并且提供了它们作为杀虫剂的使用方法。
    公开号:
    US04293552A1
  • 作为产物:
    描述:
    N-[3-bromo-5-(4-methylphenyl)pyrazin-2-yl]pyridinium aminide偶氮二异丁腈三(三甲基硅基)硅烷 作用下, 以 乙腈 为溶剂, 反应 32.0h, 以58%的产率得到2-Amino-5-(p-tolyl)pyrazine
    参考文献:
    名称:
    A New Class of Pyrazolopyridine Nucleus with Fluorescent Properties, Obtained through Either a Radical or a Pd Arylation Pathway from N-Azinylpyridinium N-Aminides
    摘要:
    The synthesis of dipyridopyrazole and pyridopyrazolopyrazine derivatives--both of which incorporate a 3-aryl moiety--can be achieved in moderate yields by intramolecular radical arylation of pyridinium N-aminides using tris(trimethylsilyl)silane and azobisisobutyronitrile. Improved results were obtained on using Pd direct arylation in conjunction with microwave irradiation. A preliminary study into the fluorescent properties of the target compounds is also reported.
    DOI:
    10.1021/jo801549u
点击查看最新优质反应信息

文献信息

  • COELENTERAZINE ANALOGUES AND COELENTERAMIDE ANALOGUES
    申请人:JNC Corporation
    公开号:US20140316137A1
    公开(公告)日:2014-10-23
    Coelenterazine analogs with different luminescence properties from conventional ones and coelenteramide analogs with different fluorescence properties from conventional ones have been desired. The invention provides coelenterazine analogs modified at the 8-position of coelenterazine and coelenteramide analogs modified at the 2- or 3-position of coelenteramide.
    寻求具有不同发光特性的螅螅素类似物和具有不同荧光特性的螅螅酰胺类似物已经被期望。该发明提供了在螅螅素的8位进行改性的螅螅素类似物,以及在螅螅酰胺的2位或3位进行改性的螅螅酰胺类似物。
  • Novel compounds that are ERK inhibitors
    申请人:Deng Yongqi
    公开号:US20070232610A1
    公开(公告)日:2007-10-04
    Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
    本发明涉及一种化学式1.0的ERK抑制剂,以及其药学上可接受的盐和溶剂。其中,Q为一个哌啶或哌嗪环,可以有一个桥或一个融合环。哌啶环中可以在环中有一个双键。所有其他取代基如定义所述。本发明还涉及使用化合物1.0治疗癌症的方法。
  • LINCOSAMIDE DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT
    申请人:Umemura Eijirou
    公开号:US20100184746A1
    公开(公告)日:2010-07-22
    An objective of the present invention is to provide compounds of formula (I) or their pharmacologically acceptable salts or solvates wherein A represents aryl while R 1 represents a five- or six-membered monocyclic heterocyclic group, or A represents a four- to six-membered monocyclic heterocyclic group while R 1 represents aryl or a five- or six-membered monocyclic heterocyclic group; R 2 represents a hydrogen atom or C 1-6 alkyl; R 3 represents C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; R 4 , R 5 , and R 6 represent a hydrogen atom; R 7 represents C 1-6 alkyl; and m is 1 to 3. The compounds are novel lincosamide derivatives that have a potent activity against resistant Streptococcus pneumoniae . Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.
    本发明的目标是提供式(I)的化合物或其药理学上可接受的盐或溶剂,其中A代表芳基,而R1代表五元或六元单环杂环基,或A代表四至六元单环杂环基,而R1代表芳基或五元或六元单环杂环基;R2代表氢原子或C1-6烷基;R3代表C1-6烷基或C3-6环烷基-C1-4烷基;R4、R5和R6代表氢原子;R7代表C1-6烷基;m为1至3。这些化合物是新型的林可霉素衍生物,对耐药性肺炎链球菌具有强效活性。此外,这些化合物可用作抗微生物剂,对预防或治疗细菌感染性疾病有用。
  • US4083977A
    申请人:——
    公开号:US4083977A
    公开(公告)日:1978-04-11
  • US4160834A
    申请人:——
    公开号:US4160834A
    公开(公告)日:1979-07-10
查看更多